open access

Vol 8, No 3 (2023)
Original article
Published online: 2023-08-22
Get Citation

Expression of KIM-1, VEGF and bFGF in the transplanted kidney as predictive factors of kidney allograft function

Tadeusz Sulikowski1, Agnieszka Orłowska-Szafrańska2, Jan Pawlus1, Jarosław Lichota1, Kazimierz Ciechanowski3, Małgorzata Marchelek-Myśliwiec3, Andrzej Brodkiewicz4, Krzysztof Safranow5, Leszek Domański3, Andrzej Pawlik6
·
Medical Research Journal 2023;8(3):234-241.
Affiliations
  1. Department of General, Minimally Invasive, and Gastroenterological Surgery, Pomeranian Medical University in Szczecin, Poland
  2. Department of Internal Diseases, Pomeranian Medical University in Szczecin, Poland
  3. Department of Nephrology, Transplantology and Internal Diseases, Pomeranian Medical University, Szczecin, Poland
  4. Clinic of Paediatrics, Nephrology, Dialysis and Treatment of Acute Poisonings, Pomeranian Medical University, Szczecin, Poland
  5. Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Szczecin, Poland
  6. Department of Physiology, Pomeranian Medical University, Szczecin, Poland

open access

Vol 8, No 3 (2023)
ORIGINAL ARTICLES
Published online: 2023-08-22

Abstract

Introduction: Transplantation is now a common treatment for kidney failure. However, it is associated with numerous complications, among which is rejection. Currently, factors that can predict the function of the transplanted kidney are being sought. This study aimed to investigate whether the expression of KIM-1 (kidney injury molecule-1), VEGF (vascular endothelial growth factor) and bFGF (basic fibroblast growth factor) assessed in the transplanted kidney before transplantation can be a predictive marker of the later function of the transplanted kidney and the occurrence of complications such as delayed graft function (DGF) and acute rejection (AR).

Material and methods: The study group included 44 kidney allograft recipients who underwent kidney transplantation.

Results: There were no statistically significant correlations between KIM-1, VEGF and bFGF gene expression in transplanted kidney biopsies and the occurrence of DGF and AR. The expression of the bFGF gene correlated significantly with the creatinine levels before and on the first day after transplantation. There were no statistically significant correlations between creatinine levels and expression of the KIM-1 and VEGF genes. There was also no statistically significant correlation between bFGF, KIM-1 and VEGF gene expression in the transplanted kidney and later eGFR and diuresis values. A statistically significant negative correlation was found between bFGF and serum potassium levels before transplantation and up to one month after transplantation. KIM-1 expression correlated significantly negatively with pre-transplant serum potassium levels. VEGF expression correlated significantly negatively with potassium levels 2 and 24 months after transplantation.

Conclusions: The present results suggest that the expression of KIM-1, VEGF and bFGF assessed in the transplanted kidney before transplantation is not a significant predictor of the later function of the transplanted kidney. The expression of the bFGF gene correlates with the creatinine levels before and on the first day after transplantation. The expression of KIM-1, VEGF and bFGF may correlate with potassium serum levels.

Abstract

Introduction: Transplantation is now a common treatment for kidney failure. However, it is associated with numerous complications, among which is rejection. Currently, factors that can predict the function of the transplanted kidney are being sought. This study aimed to investigate whether the expression of KIM-1 (kidney injury molecule-1), VEGF (vascular endothelial growth factor) and bFGF (basic fibroblast growth factor) assessed in the transplanted kidney before transplantation can be a predictive marker of the later function of the transplanted kidney and the occurrence of complications such as delayed graft function (DGF) and acute rejection (AR).

Material and methods: The study group included 44 kidney allograft recipients who underwent kidney transplantation.

Results: There were no statistically significant correlations between KIM-1, VEGF and bFGF gene expression in transplanted kidney biopsies and the occurrence of DGF and AR. The expression of the bFGF gene correlated significantly with the creatinine levels before and on the first day after transplantation. There were no statistically significant correlations between creatinine levels and expression of the KIM-1 and VEGF genes. There was also no statistically significant correlation between bFGF, KIM-1 and VEGF gene expression in the transplanted kidney and later eGFR and diuresis values. A statistically significant negative correlation was found between bFGF and serum potassium levels before transplantation and up to one month after transplantation. KIM-1 expression correlated significantly negatively with pre-transplant serum potassium levels. VEGF expression correlated significantly negatively with potassium levels 2 and 24 months after transplantation.

Conclusions: The present results suggest that the expression of KIM-1, VEGF and bFGF assessed in the transplanted kidney before transplantation is not a significant predictor of the later function of the transplanted kidney. The expression of the bFGF gene correlates with the creatinine levels before and on the first day after transplantation. The expression of KIM-1, VEGF and bFGF may correlate with potassium serum levels.

Get Citation

Keywords

KIM-1, VEGF, bFGF, kidney, allograft

About this article
Title

Expression of KIM-1, VEGF and bFGF in the transplanted kidney as predictive factors of kidney allograft function

Journal

Medical Research Journal

Issue

Vol 8, No 3 (2023)

Article type

Original article

Pages

234-241

Published online

2023-08-22

Page views

147

Article views/downloads

252

DOI

10.5603/mrj.95927

Bibliographic record

Medical Research Journal 2023;8(3):234-241.

Keywords

KIM-1
VEGF
bFGF
kidney
allograft

Authors

Tadeusz Sulikowski
Agnieszka Orłowska-Szafrańska
Jan Pawlus
Jarosław Lichota
Kazimierz Ciechanowski
Małgorzata Marchelek-Myśliwiec
Andrzej Brodkiewicz
Krzysztof Safranow
Leszek Domański
Andrzej Pawlik

References (27)
  1. Bahl D, Haddad Z, Datoo A, et al. Delayed graft function in kidney transplantation. Curr Opin Organ Transplant. 2019; 24(1): 82–86.
  2. Hu XJ, Zheng J, Li Y, et al. Prediction of kidney transplant outcome based on different DGF definitions in Chinese deceased donation. BMC Nephrol. 2019; 20: 409.
  3. Parajuli S, Muth BL, Astor BC, et al. Delayed kidney graft function in simultaneous pancreas-kidney transplant recipients is associated with early pancreas allograft failure. Am J Transplant. 2020; 20(10): 2822–2831.
  4. Rolak S, Djamali A, Mandelbrot DA, et al. Outcomes of delayed graft function in kidney transplant recipients stratified by histologic biopsy findings. Transplant Proc. 2021; 53(5): 1462–1469.
  5. Li M, Dai Y, Lei J, et al. Acute rejection after kidney transplantation promotes graft fibrosis with elevated adenosine level in rat. PLoS One. 2017; 12(6): e0180211.
  6. Rodríguez Castellanos FE, Domínguez Quintana F, Soto Abraham V, et al. Classification of acute rejection episodes in transplantation: a proposal based on factor analysis. Iran J Kidney Dis. 2018; 12(2): 123–131.
  7. Dharnidharka VR, Malone A. Biomarkers to detect rejection after kidney transplantation. Pediatr Nephrol. 2018; 33(7): 1113–1122.
  8. Han WK, Bailly V, Abichandani R, et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002; 62(1): 237–244.
  9. Vaidya VS, Ramirez V, Ichimura T, et al. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol. 2006; 290(2): F517–F529.
  10. van Timmeren MM, van den Heuvel MC, Bailly V, et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007; 212(2): 209–217.
  11. Nogare AL, Joelsons G, Pedroso JAR, et al. Quantitative analyses of kidney injury molecule-1 messenger RNA in kidney transplant recipients with graft dysfunction. Transplant Proc. 2010; 42(2): 473–474.
  12. Zhang PL, Rothblum LI, Han WK, et al. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int. 2008; 73(5): 608–614.
  13. Vaidya VS, Waikar SS, Ferguson MA, et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008; 1(3): 200–208.
  14. Ferrara N, Henzel WJ, Ferrara N, et al. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989; 161(2): 851–858.
  15. Liu E, Morimoto M, Kitajima S, et al. Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. J Am Soc Nephrol. 2007; 18(7): 2094–2104.
  16. Sharma A, Jain S, Gupta R, et al. Ultrastructural alterations in endothelial mitochondria are associated with enhanced nitrotyrosine accumulation and progressive reduction of VEGF expression in sequential protocol renal allograft biopsies with calcineurin inhibitor toxicity. Transpl Int. 2010; 23(4): 407–416.
  17. Minchenko A, Bauer T, Salceda S, et al. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest. 1994; 71(3): 374–379.
  18. Kim NH, Oh JH, Seo JiA, et al. Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney Int. 2005; 67(1): 167–177.
  19. Pilmore HL, Eris JM, Painter DM, et al. Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation. 1999; 67(6): 929–933.
  20. Poon RT, Fan ST, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol. 2001; 19(4): 1207–1225.
  21. Pałgan I, Czerwionka-Szaflarska M, Pałgan K, et al. [Assessment of serum levels of some angiogenic factors in healthy children]. Wiad Lek. 2004; 57(7–8): 343–346.
  22. Villanueva S, Cespedes C, Gonzalez AA, et al. bFGF induces an earlier expression of nephrogenic proteins after ischemic acute renal failure. Am J Physiol Regul Integr Comp Physiol. 2006; 291(6): R1677–R1687.
  23. Sugimoto H, Hamano Y, Charytan D, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem. 2003; 278(15): 12605–12608.
  24. Radomsky ML, Thompson AY, Spiro RC, et al. Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthop Relat Res. 1998(355 Suppl): S283–S293.
  25. Yafai Y, Iandiev I, Lange J, et al. Basic fibroblast growth factor contributes to a shift in the angioregulatory activity of retinal glial (Müller) cells. PLoS One. 2013; 8(7): e68773.
  26. Li Y, Hendrickson A, et al. Regulation of retinal capillary cells by basic fibroblast growth factor, vascular endothelial growth factor, and hypoxia. In Vitro Cell Dev Biology Anim. 2001; 37(1): 45–49, doi: 10.1290/1071-2690(2001)037<0045:rorccb>2.0.co;2.
  27. Seghezzi G, Patel S, Ren CJ, et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol. 1998; 141(7): 1659–1673.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl